← Leaderboards
Everett Meyer
Stanford University
$8,240,367
Attributed
$10,917,698
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,657,361 · 7
By mechanism
P01$4,414,577 · 3
R01$3,097,818 · 1
U01$2,931,432 · 1
UC4$1,446,086 · 1
K08$767,448 · 1
Top collaborators
- Seung K Kim5 shared
- Alvin Carter Powers4 shared
Most similar at Stanford University
Same institution · by research overlap
- Samuel Strober$36,157,957
- Robert S Negrin$29,816,136
- Edgar G. Engleman$35,389,843
- Judith Anne Shizuru$11,975,284
- Asha Bhaskaran Pillai$2,775,962
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneCellsPre-Clinical ModelResearch PersonnelBaseCell TherapyPreventClinical TrialsT-LymphocyteRegulatory T-LymphocyteIl2ra GeneAntigensTransplantationTechnologyBone Marrow TransplantationBiologyImmunosuppressive AgentsImmunologic MonitoringImmunoregulationMonitorT-Cell ReceptorEngineeringChimeric Antigen ReceptorBiobank
Grant awards (20)
Engineered Immune Cells for T1D$760,043
R01 · FY2025 · DK · contact PI
Engineered Immune Cells for T1D$767,617
R01 · FY2024 · DK · contact PI
Engineered Immune Cells for T1D$778,837
R01 · FY2023 · DK · contact PI
Core C: Cell Processing and Immune Monitoring Core$537,148
P01 · FY2023 · CA · contact PI
Engineered Immune Cells for T1D$791,321
R01 · FY2022 · DK · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$709,922
U01 · FY2022 · DK
Core C: Cell Processing and Immune Monitoring Core$526,404
P01 · FY2022 · CA · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$722,946
U01 · FY2021 · DK
Core C: Cell Processing and Immune Monitoring Core$537,148
P01 · FY2021 · CA · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,739,663
P01 · FY2020 · HL · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$735,602
U01 · FY2020 · DK
Core C: Cell Processing and Immune Monitoring Core$537,125
P01 · FY2020 · CA · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$762,962
U01 · FY2019 · DK
Core C: Cell Processing and Immune Monitoring Core$537,089
P01 · FY2019 · CA · contact PI
T-cell monitoring and immunotherapy for treating graft-versus-host disease$168,048
K08 · FY2018 · HL · contact PI
CAR T cell targeting of human islets$1,446,086
UC4 · FY2017 · DK
T-cell monitoring and immunotherapy for treating graft-versus-host disease$168,048
K08 · FY2017 · HL · contact PI
T-cell monitoring and immunotherapy for treating graft-versus-host disease$168,048
K08 · FY2016 · HL · contact PI
T-cell monitoring and immunotherapy for treating graft-versus-host disease$131,652
K08 · FY2015 · HL · contact PI
T-cell monitoring and immunotherapy for treating graft-versus-host disease$131,652
K08 · FY2014 · HL · contact PI